Precise Insights
Advanced Data & AI for AML
On-demand access to the largest and most sophisticated oncology data for accelerated RWE and improved patient outcomes.
labs
Results from longitudinal blood tests (CBCs)
Visits
Hematology-oncology practice encounters
Observations
Tumor-related observations plus vitals, biometrics, pain, and more
Procedures
Transplants, Transfusions
Medications
Start and end dates, brand vs. generic codes, dosage, duration, and cycles
Social Determinants
Social and physical environment factors
ECOG
Performance score
Diagnoses
Disease sub-type (WHO), Risk and Prognosis
full ngs panel
Complete genomic report with treatment exposure and clinical outcomes
Disease Progression
Directly-observed measures of critical endpoints
Adverse Events
Confirm the adverse event and link to treatment discontinuation
Cost & Utilization
Adjudicated costs with linked claims data
Safety, Comorbidities
Pre-cancer and claims charge events
Specialty Pharmacy & Hub
Rx acquisition status details
Payer & Formulary
Drug tiers and coverage
Cancer Subtype
Cancer type when ICD code is unknown
Date of Initial Dx
Impute index event
Line of Therapy
Regimen or progression-based drug classes
Patient Adherence
Identify root cause of product switching
Patient Acquisition
Predict factors driving patients’ brand decision